Edition:
United States

Auris Medical Holding Ltd (EARS.OQ)

EARS.OQ on NASDAQ Stock Exchange Capital Market

2.64USD
16 Aug 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.64
Open
$2.61
Day's High
$2.75
Day's Low
$2.61
Volume
5,071
Avg. Vol
39,797
52-wk High
$39.20
52-wk Low
$2.42

About

Auris Medical Holding AG is a Switzerland-based biotechnology company engaged in developing pharmaceutical products for the treatment of inner ear disorders and mental health supportive care. The Company focuses on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the treatment of antipsycho... (more)

Overall

Beta: --
Market Cap(Mil.): $32.28
Shares Outstanding(Mil.): 34.33
Dividend: --
Yield (%): --

Financials

  EARS.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -0.74 -- --
ROI: -112.79 8.94 14.48
ROE: -167.38 10.07 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates